Biotechnologies and Pharmaceuticals sector in Russia
Russia is the largest market in Central and Eastern Europe, and among the ten largest pharmaceutical markets in the world (it took 7th place at the end of 2012)
According to the DSM Group, the value of Russian pharmaceutical market in 2012 amounted to 921 billion roubles in consumer process, which is 12% more than in 2011. Russia was ranked third in the world for growth rate.
This market heavily depends on imports. The value of pharmaceuticals import to Russia in 2012 amounted to 14.4 billion US dollars, which is 9% higher than in 2011 (DSM Group Data)
Russia’s entry to the WTO should provide a clearer regulatory pathway for foreign original drug makers through strong intellectual property (IP) legislation.
Russian pharmaceutical producers will have to switch to Good Manufacturing Practice (GMP) standards starting from January 1, 2014. This opens opportunities for UK providers of GMP compliant technology and equipment..
Getting into the market
Market intelligence is critical when doing business overseas, and UKTI can provide bespoke market research and support during overseas visits though our chargeable Overseas Market Introduction Service (OMIS).
To commission research or for general advice about the market, get in touch with our specialists in country – or contact your local international trade team.
Elena Anisina, British Consulate General in Ekaterinburg Tel: +7 343 253 5605 or email: [email protected]
Maria Semchenkova, British Embassy Moscow
Tel: +7 495 956 7372 or email: [email protected]
UKTI runs a range of events for exporters, including seminars in the UK, trade missions to overseas markets and support for attendance at overseas trade shows.
Date: 25-28 November 2013
Apteka (part of Zdravookhraneniye)
Date: 9-13 December 2013